Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > VNDA > Summary

Vanda Pharmaceuticals, Inc.
(VNDA)

10.60USD   Up0.40 (3.92%)   
At 2:30AM IST
 Vanda Pharmaceuticals, Inc. (NGM:VNDA) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 10.60USD
Trade Time:2:30AM IST
Change:Up0.40 (3.92%)
Prev Close:10.20
Open:10.34
Bid:N/A
Ask:10.89 x 2000
1y Target Est:22.00
Day's Range:10.24 - 10.66
52wk Range:0.60 - 16.65
Volume:269,352
Avg Vol (3m):461,687
Market Cap:288.33M
P/E (ttm):N/A
EPS (ttm):-1.27
Div & Yield:N/A (N/A%)
Add VNDA to Portfolio   Download Data

HEADLINES

 
•Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 16, 2010 - PR Newswire  - Wed 12:39AM
•These Stocks Can Easily Double Your Money - Motley Fool  - Thu, Jan 21
•Competitive Schizophrenia Market - Zacks.com  - Wed, Jan 13
•VANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex - EDGAR Online  - Tue, Jan 12
•Drug News: Impotence, Arthritis and Schizophrenia - The Wall Street Journal Online  - Tue, Jan 12
•Sales start for Vanda Pharmaceuticals schizophrenia treatment - bizjournals.com  - Mon, Jan 11
•Fanapt(TM) Launches in the U.S. - PR Newswire  - Mon, Jan 11
•Biotech's Movers and Shakers 2009: BioBuzz - TheStreet.com  - Mon, Jan 4
•Biotech's Movers & Shakers 2009: BioBuzz - TheStreet.com  - Mon, Jan 4
•Biotech's 2009 Movers & Shakers: BioBuzz - TheStreet.com  - Mon, Jan 4
•Nasdaq 2009 Winners & Losers - TheStreet.com  - Fri, Jan 1
•Millennial Stocks - Up By Over 1,000% In 2009 - Investopedia  - Fri, Jan 1
» More Headlines for VNDA...

ANALYST

 
EPS Est (next year) (Dec-09) :-1.14
EPS Est (in 2 years) (Dec-10) :-0.31
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Vanda Pharmaceuticals Inc., a biopharmaceutical company, engages in the development and commercialization of clinical-stage drug candidates for central nervous system disorders.

» Full Company Profile